Navigation Links
Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
Date:9/25/2013

Irvine, CA (PRWEB) September 25, 2013

Proove Biosciences Inc. (http://www.proovebio.com), the leading personalized pain medicine laboratory, announces that they will again be presenting research on the genetics of pain medicine at a major scientific meeting this year. This weekend, Proove will present preliminary findings from a clinical study during the poster session and will exhibit at the American Academy of Pain Management’s 24th Annual Clinical Meeting at the JW Marriott Orlando, Orlando, Florida. The event will be held from September 26th to September 29nd. Proove will be presenting research on the clinical and economic outcomes of using the Proove Narcotic Risk Genetics Test in the treatment and management of pain.

The American Academy of Pain Management is the one of largest pain management organizations in the nation and uniquely embraces an integrative model of care, which includes bringing together all appropriate therapeutic approaches and a team of clinicians to reduce pain and achieve optimal health and healing. The AAPM also offers continuing education, publications, and advocacy.

Proove Biosciences CEO, Brian Meshkin, states, “We are pleased to again have our research selected by experts in the field to be presented at another industry leading conference. The AAPM’s Annual Clinical Meeting brings together over 1200 clinicians across all disciplines in pain management, and offers Proove another opportunity to help educate about the importance of using genetic testing in pain management.”

Proove will be exhibiting at the scientific meeting to help educate clinicians about its proprietary genetic testing to personalize pain medicine and will be presenting some additional preliminary data at the poster session on the R.A.C.E.R. Study,”Retrospective Analysis of the Clinical and Economic Results (R.A.C.E.R.) of Genotyping Chronic Pain Patients to Guide Medical Detoxification of Prescription Opioid Analgesic Abuse (RxO): Two-Year Study.” In this study, principal investigator, Dr. Gregory Smith, utilized an integrated, team-based medical approach to detoxification. In the R.A.C.E.R. Study, Proove investigators conducted a pilot study to explore how genotyping could correlate or associate with outcomes of medical detoxification, and whether genotype could predict outcomes. At this meeting, researchers will prevent preliminary findings that suggest the Proove Narcotic Risk test may assist clinicians in improving outcomes of medical detoxification in patients abusing prescription narcotic pain medication.

About Proove Biosciences
Proove Biosciences is the leading Personalized Pain Medicine laboratory that provides proprietary genetic testing services to help physicians improve outcomes for patients and contain costs for insurers. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve pain medicine selection, dosing, and evaluation of medications they prescribe. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proovebio.com or call toll free 855-PROOVE-BIO (855-776-6832).

Read the full story at http://www.prweb.com/releases/2013/9/prweb11160656.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
5. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
6. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
7. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
8. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
9. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
10. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
11. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 10, 2016  Matchbook, Inc., a company specializing ... biotech companies, announced today the appointment of ... Jim brings nearly 25 years of experience in ... spent nearly two decades in executive level roles ... at Genzyme and, most recently headed global logistics ...
(Date:2/10/2016)... ... 2016 , ... SonaCare Medical, LLC reports the introduction of ... monitoring. The inaugural launch of this new technology occurred over the course of ... to a HIFU technical expert at SonaCare Medical headquarters. , Sonalink allows ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Cenna Bioscience ... for the treatment of Alzheimer’s disease, announced today it has been selected to present ... at the Breakers in Palm Beach, Florida. The purpose of the Forum is ...
(Date:2/9/2016)... ... 08, 2016 , ... Date and time: March 1, 2016, ... Pennsylvania Biotechnology Center of Bucks County, 3805 Old Easton Road, Doylestown, PA 18902. ... hold an open house for participants to learn about a new Master of ...
Breaking Biology Technology:
(Date:2/4/2016)... , Feb. 4, 2016 The field ... one of the most popular hubs of the ... and other huge studies of human microbiota, have ... few years, the microbiome space has literally exploded ... research. This report focuses on biomedical aspects ...
(Date:2/3/2016)... 3, 2016 --> ... report "Automated Fingerprint Identification System Market by Component (Hardware ... (Banking & Finance, Government, Healthcare, and Transportation) and Geography ... market is expected to be worth USD 8.49 Billion ... 2015 and 2020. The transformation and technology evolution from ...
(Date:2/3/2016)... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) ... "Emotion Detection and Recognition Market by Technology ... Tools (Facial Expression, Voice Recognition and Others), ... Global forecast to 2020" report to ... ) has announced the addition of the ...
Breaking Biology News(10 mins):